MiR-758-3p regulates papillary thyroid cancer cell proliferation and migration by targeting TAB1.
Pharmazie
; 74(4): 235-238, 2019 04 01.
Article
in En
| MEDLINE
| ID: mdl-30940308
Previous studied revealed that miR-758-3p was abnormally expressed in cancer patients. However, its role and underlying mechanism in papillary thyroid cancer (PTC) remains unclear. Expression of miR-758-3p in PTC cell lines was analyzed using quantitative real-time PCR. It was observed that miR-758-3p expression was significantly downregulated in PTC cell lines. Overexpression of miR-758-3p inhibited PTC cell proliferation, invasion but promoted cell apoptosis in vitro. Further study demonstrated that TGF-ß activated kinase 1 binding protein 1 (TAB1) was a direct target of miR-758-3p and TAB1 expression was suppressed by miR-758-3p overexpression. Moreover, TAB1 was shown to be a mediator for the roles of miR-758-3p in PTC. Therefore, our study established a tumor-suppressive role for miR-758-3p in the inhibition of PTC progression, which may be employed as a novel prognostic marker and as an effective therapeutic target for PTC.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
MicroRNAs
/
Adaptor Proteins, Signal Transducing
/
Thyroid Cancer, Papillary
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Pharmazie
Journal subject:
FARMACIA
Year:
2019
Document type:
Article
Country of publication:
Alemania